One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like 2Seventy Bio Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell 2Seventy Bio Inc’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding 2Seventy Bio Inc’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About 2Seventy Bio Inc (TSVT)

Before we jump into 2Seventy Bio Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

2seventy bio, Inc. is a cell and gene therapy company, which is focused on the research, development, and commercialization of transformative treatments for cancer. Its approach combines its expertise in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. The Company?s advancing multiple clinical programs, including SC-DARIC33, for the treatment of pediatric patients with relapsed and refractory acute myeloid leukemia (AML), and bbT369, for the treatment of patients with B-cell non-Hodgkins lymphoma, or B-NHL, as well as multiple preclinical programs, including bbT4015, an engineered CAR T cell therapy targeting MUC16. Additionally, together with its partner Bristol Myers Squibb, the Company is delivering Abecma to multiple myeloma patients in the United States.

Want to learn more about 2Seventy Bio Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about 2Seventy Bio Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

2Seventy Bio Inc’s Stock Price as of Market Close

As of July 24, 2023, 4:00 PM CST, 2Seventy Bio Inc’s stock price was $9.83.

2Seventy Bio Inc is down 5.84% from its previous closing price of $10.44.

During the last market session, 2Seventy Bio Inc’s stock traded between $10.37 and $10.82. Currently, there are 43.47 million shares of 2Seventy Bio Inc stock available for purchase.

Unfortunately, 2Seventy Bio Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

2Seventy Bio Inc Stock Price History

2Seventy Bio Inc’s (TSVT) price is currently down 2.87% so far this month.

During the month of July, 2Seventy Bio Inc’s stock price has reached a high of $11.29 and a low of $9.77.

Over the last year, 2Seventy Bio Inc has hit prices as high as $18.88 and as low as $8.25. Year to date, 2Seventy Bio Inc’s stock is down 61.65%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused 2Seventy Bio Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 21, 2023, there were 3 analysts who downgraded 2Seventy Bio Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate 2Seventy Bio Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

2Seventy Bio Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about 2Seventy Bio Inc (TSVT) by visiting AAII Stock Evaluator.

Relative Price Strength of 2Seventy Bio Inc

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of July 21, 2023, 2Seventy Bio Inc has a weighted four-quarter relative price strength of -3.25%, which translates to a Momentum Score of 51 and is considered to be Average.

Want to learn more about how 2Seventy Bio Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

2Seventy Bio Inc Stock Price: Bottom Line

As of July 24, 2023, 2Seventy Bio Inc’s stock price is $9.83, which is down 5.84% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell 2Seventy Bio Inc’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.